Literature DB >> 11531828

The therapeutic use of topical contact sensitizers in benign dermatoses.

D A Buckley1, A W Du Vivier.   

Abstract

Topical therapy using contact sensitizers has been practised since the 1960s to treat conditions associated with an altered immunological state. Dinitrochlorobenzene, squaric acid dibutyl ester and diphencyprone are most commonly employed in the therapy of alopecia areata and viral warts. Few dermatology departments in the U.K. provide such treatment. This systematic review discusses the various contact sensitizers used for topical immunotherapy, the methodology of treatment, factors influencing efficacy and likely adverse effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531828     DOI: 10.1046/j.1365-2133.2001.04399.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Drug discovery for alopecia: gone today, hair tomorrow.

Authors:  Zenildo Santos; Pinar Avci; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2015-02-09       Impact factor: 6.098

2.  Generalized molluscum contagiosum in an HIV patient treated with diphencyprone.

Authors:  Leena Chularojanamontri; Papapit Tuchinda; Kanokvalai Kulthanan; Woraphong Manuskiatti
Journal:  J Dermatol Case Rep       Date:  2010-12-31

Review 3.  Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata.

Authors:  Kun-Wei Lai; Tsen-Fang Tsai
Journal:  Dermatol Ther (Heidelb)       Date:  2022-09-22

4.  Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata.

Authors:  M Zöller; P Freyschmidt-Paul; M Vitacolonna; K J McElwee; S Hummel; R Hoffmann
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 5.  Developments in Intralesional Therapy for Metastatic Melanoma.

Authors:  Sarah Sloot; Omar M Rashid; Arnod A Sarnaik; Jonathan S Zager
Journal:  Cancer Control       Date:  2016-01       Impact factor: 3.302

Review 6.  Intralesional treatment of metastatic melanoma: a review of therapeutic options.

Authors:  Benjamin Weide; Dario Neri; Giuliano Elia
Journal:  Cancer Immunol Immunother       Date:  2017-01-11       Impact factor: 6.968

7.  Topical immunotherapy in alopecia areata.

Authors:  Gurcharan Singh; Ms Lavanya
Journal:  Int J Trichology       Date:  2010-01

Review 8.  Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update.

Authors:  Thipprapai Mahasaksiri; Chaninan Kositkuljorn; Tanaporn Anuntrangsee; Poonkiat Suchonwanit
Journal:  Drug Des Devel Ther       Date:  2021-03-23       Impact factor: 4.162

Review 9.  Hapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunity.

Authors:  Dan A Erkes; Senthamil R Selvan
Journal:  J Immunol Res       Date:  2014-05-15       Impact factor: 4.818

10.  A Case Report of Verruca Vulgaris on basis of Alopecia Areata Successfully Treated with Diphenylcyclopropenone.

Authors:  Tugba Kevser Uzuncakmak; Mahmut Can Koska; Ayşe Serap Karadağ; Necmettin Akdeniz
Journal:  Int J Trichology       Date:  2017 Jan-Mar
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.